Who We Are: Driven to Transform Healthcare
We are a global, science-led, patient-focused pharmaceutical business. At AstraZeneca, We are committed to excellence in the research, development and commercialisation of prescription medicines. We aim to transform the lives of patients with improved outcomes and a better quality of life.
We deliver a diversified portfolio of medicines across primary care, specialty care and rare diseases through our broad-based global network. Through our work in BioPharmaceuticals, we want to transform healthcare, change the lives of billions of people for the better and address some of the biggest healthcare challenges facing humankind. There remains a huge unmet need in treating people with chronic diseases. Our ambition is to stop the progress of these often degenerative, debilitating and life-threatening conditions. So many more people can live better, healthier lives.
Our BioPharmaceuticals R&D and Business Unit are unified in our approach to deliver life-changing medicines for people living with the most common chronic diseases. BioPharmaceuticals is responsible for our key therapy areas of Cardiovascular, Renal & Metabolism and Respiratory & Immunology and Vaccines & Immune Therapies.
